PTC Therapeutics Statistics
Total Valuation
PTCT has a market cap or net worth of $5.62 billion. The enterprise value is $6.41 billion.
| Market Cap | 5.62B |
| Enterprise Value | 6.41B |
Important Dates
The last earnings date was Thursday, July 30, 2026, after market close.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTCT has 83.46 million shares outstanding. The number of shares has decreased by -0.11% in one year.
| Current Share Class | 83.46M |
| Shares Outstanding | 83.46M |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | +11.51% |
| Owned by Insiders (%) | 2.44% |
| Owned by Institutions (%) | 113.00% |
| Float | 73.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 58.38 |
| PS Ratio | 5.57 |
| Forward PS | 4.51 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.36 |
| EV / EBITDA | 37.45 |
| EV / EBIT | 55.31 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.39
| Current Ratio | 3.39 |
| Quick Ratio | 3.20 |
| Debt / Equity | n/a |
| Debt / EBITDA | 15.67 |
| Debt / FCF | n/a |
| Interest Coverage | 0.61 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 2.46% |
| Return on Invested Capital (ROIC) | 5.24% |
| Return on Capital Employed (ROCE) | 4.68% |
| Weighted Average Cost of Capital (WACC) | 6.44% |
| Revenue Per Employee | $1.02M |
| Profits Per Employee | -$38,731 |
| Employee Count | 991 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 8.05 |
Taxes
| Income Tax | -28.69M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.32% in the last 52 weeks. The beta is 0.54, so PTCT's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +15.32% |
| 50-Day Moving Average | 74.94 |
| 200-Day Moving Average | 73.22 |
| Relative Strength Index (RSI) | 36.18 |
| Average Volume (20 Days) | 820,222 |
Short Selling Information
The latest short interest is 10.22 million, so 12.25% of the outstanding shares have been sold short.
| Short Interest | 10.22M |
| Short Previous Month | 10.57M |
| Short % of Shares Out | 12.25% |
| Short % of Float | 13.88% |
| Short Ratio (days to cover) | 8.26 |
Income Statement
In the last 12 months, PTCT had revenue of $1.01 billion and -$38.38 million in losses. Loss per share was -$0.47.
| Revenue | 1.01B |
| Gross Profit | 503.97M |
| Operating Income | 115.93M |
| Pretax Income | -67.07M |
| Net Income | -38.38M |
| EBITDA | 171.23M |
| EBIT | 115.93M |
| Loss Per Share | -$0.47 |
Balance Sheet
The company has $2.23 billion in cash and $3.02 billion in debt, with a net cash position of -$788.82 million or -$9.45 per share.
| Cash & Cash Equivalents | 2.23B |
| Total Debt | 3.02B |
| Net Cash | -788.82M |
| Net Cash Per Share | -$9.45 |
| Equity (Book Value) | -165.36M |
| Book Value Per Share | -1.98 |
| Working Capital | 1.85B |
Cash Flow
In the last 12 months, operating cash flow was -$30.50 million and capital expenditures -$9.28 million, giving a free cash flow of -$39.78 million.
| Operating Cash Flow | -30.50M |
| Capital Expenditures | -9.28M |
| Depreciation & Amortization | 55.30M |
| Net Borrowing | 207.62M |
| Free Cash Flow | -39.78M |
| FCF Per Share | -$0.48 |
Margins
Gross margin is 49.96%, with operating and profit margins of 11.49% and -3.80%.
| Gross Margin | 49.96% |
| Operating Margin | 11.49% |
| Pretax Margin | -6.65% |
| Profit Margin | -3.80% |
| EBITDA Margin | 16.97% |
| EBIT Margin | 11.49% |
| FCF Margin | n/a |
Dividends & Yields
PTCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.11% |
| Shareholder Yield | 0.11% |
| Earnings Yield | -0.68% |
| FCF Yield | -0.71% |
Analyst Forecast
The average price target for PTCT is $99.29, which is 47.38% higher than the current price. The consensus rating is "Buy".
| Price Target | $99.29 |
| Price Target Difference | 47.38% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | -2.63% |
| EPS Growth Forecast (3Y) | -23.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTCT has an Altman Z-Score of 0.82 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.82 |
| Piotroski F-Score | 2 |